CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-11-01 12:05 Tx date 2024-11-01	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-14,348.84 -65,222 vol $0.22 each	0
Filed 2024-11-01 12:05 Tx date 2024-11-01	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-230.00 -1,000 vol $0.23 each	65,222
Filed 2024-11-01 12:05 Tx date 2024-10-31	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-115.00 -500 vol $0.23 each	66,222
Filed 2024-11-01 12:04 Tx date 2024-10-30	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,265 -5,500 vol $0.23 each	66,722
Filed 2024-09-23 16:03 Tx date 2024-09-20	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$17,333 +72,222 vol $0.24 each	72,222
Filed 2024-09-23 16:03 Tx date 2024-09-20	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 38 - Redemption, retraction, cancellation, repurchase	-38,889 vol	111,111
Filed 2024-09-23 16:02 Tx date 2024-09-20	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-72,222 vol	150,000
Filed 2024-09-23 15:59 Tx date 2024-09-06	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-17,333.28 -72,222 vol $0.24 each	0
Filed 2024-09-23 14:09 Tx date 2024-09-06	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 10 - Acquisition or disposition in the public market	-72,222 vol
Filed 2024-09-12 07:35 Tx date 2024-09-06	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 10 - Acquisition or disposition in the public market	-72,222 vol
Filed 2024-09-12 07:35 Tx date 2024-09-06	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 10 - Acquisition or disposition in the public market	-72,222 vol	150,000
Filed 2024-03-28 10:49 Tx date 2024-03-25	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+72,222 vol	72,222
Filed 2024-03-28 10:49 Tx date 2020-01-22	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-03-28 10:49 Tx date 2024-03-25	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 38 - Redemption, retraction, cancellation, repurchase	-38,889 vol	222,222
Filed 2024-03-28 10:48 Tx date 2024-03-25	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-72,222 vol	261,111
Filed 2024-03-18 11:52 Tx date 2024-03-14	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+333,333 vol	333,333
Filed 2024-03-18 11:51 Tx date 2020-01-22	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-08-15 15:06 Tx date 2023-08-11	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+225,000 vol	775,000
Filed 2021-09-09 14:43 Tx date 2021-09-02	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+150,000 vol	550,000
Filed 2020-04-30 20:51 Tx date 2020-04-19	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	400,000
Filed 2020-04-30 15:56 Tx date 2020-01-22	$INNO InnoCan Pharma Corporation	Bloch, Peter David 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report